A Brief Analysis Of China's Foreign Trade Of Pharmaceutical Products From January To April T2022
Date of issue: 09/17/2022
CPhI World Pharmaceutical Raw Materials China Exhibition
Since 2022, global COVID - 19 outbreak continues to wreak havoc, the conflict between Russia and Ukraine to slow recovery of the global economy again encounter setbacks, sharp increases in commodity prices, inflationary pressures and continue to intensify the pressure on the supply chain, global trade recovery under pressure At the same time, more frequent domestic outbreak, for part of the production and operation of an enterprise supply chain stability produced bigger pressure In this case, with the implementation of a series of stable foreign trade policies, and the inherent advantages of China's pharmaceutical industry chain support, the foreign trade of pharmaceutical products has maintained a steady development. Among them, imports reached 28.6 billion US dollars, up 0.67% year on year; Exports reached us $55.31 billion, up 1.5% year on year.
From January to April, the export of Western medicine preparations was usd 2.24 billion, up 25.8% year-on-year, the export volume increased 4.2%year-on-year, and the average export price increased 20.7% year-on-year. Among them, the export volume of hormone preparations increased by 103.8%, mainly driven by the significant growth of insulin preparations. The export volume of penicillin preparations increased by 25% year on year, cephalosporins remained flat year on year, other Western medicines increased by 9.1% year on year, and the export volume of biochemical drugs increased by 38.4% year on year, and the average export price decreased by 44.6% year on year This was mainly caused by a sharp drop in the export of human vaccines, which dropped by 72.8% from January to April this year.
